FIRM ANALYST
Cantor Fitzgerald
Brandon Folkes
Citi
Yigal Nochomovitz
H.C. Wainwright
Andrew Fein
Mizuho Securities
Salim Syed
Roth Capital
Elemer Piros
Wedbush
Andreas Argyrides
The analysts above have initiated and are maintaining formal research coverage of Unity Biotechnology. Please note that any opinions, estimates or forecasts regarding Unity Biotechnology’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Unity Biotechnology or Unity Biotechnology’s management. Unity Biotechnology does not by reference above or distribution of same imply endorsement of or concurrence with any analyst’s opinions, estimates, forecasts, conclusions or recommendations. Unity Biotechnology does not participate in the preparation of analysts’ reports and undertakes no obligation to verify or correct any information in such reports.
https://ir.unitybiotechnology.com/financial-information/analyst-coverage
It is understood that all posts on the site are to be considered opinions. They do not need to indicate this in their posts.
Readers determine the veracity of the posts they read and the credibility of other Users
Recent UBX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 09:05:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:05:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/11/2023 05:15:29 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/08/2023 09:39:06 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/06/2023 10:25:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 12:00:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 08:05:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 08:05:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2023 11:05:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/15/2023 08:08:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/15/2023 08:07:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 08:05:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 08:07:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 08:04:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 08:13:01 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/03/2023 08:13:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2023 08:05:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/01/2023 08:04:47 PM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM